Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. S-800342
2. Sl 80-0342
1. 82626-01-5
2. Ananxyl
3. 2-(6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide
4. Sl 80.0342-00
5. 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide
6. 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-n,n-dipropylacetamide
7. Chembl54349
8. I93sc245qz
9. Sl-80.0342-00
10. 6-chlor-2-(4-chlorphenyl)-n,n-dipropylimidazol(1,2-a)pyridin-3-acetamid
11. Alpidemum [latin]
12. Ncgc00182850-01
13. Imidazo(1,2-a)pyridine-3-acetamide, 6-chloro-2-(4-chlorophenyl)-n,n-dipropyl-
14. Dsstox_cid_28972
15. Dsstox_rid_83237
16. Dsstox_gsid_49046
17. Alpidemum
18. Cas-82626-01-5
19. Alpidem [usan:inn:ban]
20. Unii-i93sc245qz
21. S-800342
22. Alpidem-[d14]
23. Alpidem (usan/inn)
24. Alpidem [usan]
25. Alpidem [inn]
26. Alpidem [mi]
27. Alpidem [mart.]
28. Alpidem [who-dd]
29. Schembl122619
30. Dtxsid8049046
31. Bdbm22041
32. Chebi:135649
33. Zinc599598
34. Tox21_113593
35. Alpidem, >=98% (hplc), Powder
36. Pdsp1_000633
37. Pdsp2_000628
38. Akos016014168
39. Tox21_113593_1
40. Cs-w013866
41. Hy-w013150
42. Ncgc00182850-02
43. Ft-0630911
44. D02833
45. A930152
46. Sr-01000944944
47. Q4735440
48. Sr-01000944944-1
49. 2-(6-chloro-2-(4-chlorophenyl)h-imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide
Molecular Weight | 404.3 g/mol |
---|---|
Molecular Formula | C21H23Cl2N3O |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 7 |
Exact Mass | 403.1218178 g/mol |
Monoisotopic Mass | 403.1218178 g/mol |
Topological Polar Surface Area | 37.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 478 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
ABOUT THIS PAGE
A Alpidem manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alpidem, including repackagers and relabelers. The FDA regulates Alpidem manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alpidem API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Alpidem supplier is an individual or a company that provides Alpidem active pharmaceutical ingredient (API) or Alpidem finished formulations upon request. The Alpidem suppliers may include Alpidem API manufacturers, exporters, distributors and traders.
click here to find a list of Alpidem suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alpidem DMF (Drug Master File) is a document detailing the whole manufacturing process of Alpidem active pharmaceutical ingredient (API) in detail. Different forms of Alpidem DMFs exist exist since differing nations have different regulations, such as Alpidem USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alpidem DMF submitted to regulatory agencies in the US is known as a USDMF. Alpidem USDMF includes data on Alpidem's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alpidem USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alpidem suppliers with USDMF on PharmaCompass.
Alpidem Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alpidem GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alpidem GMP manufacturer or Alpidem GMP API supplier for your needs.
A Alpidem CoA (Certificate of Analysis) is a formal document that attests to Alpidem's compliance with Alpidem specifications and serves as a tool for batch-level quality control.
Alpidem CoA mostly includes findings from lab analyses of a specific batch. For each Alpidem CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alpidem may be tested according to a variety of international standards, such as European Pharmacopoeia (Alpidem EP), Alpidem JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alpidem USP).
LOOKING FOR A SUPPLIER?